Cargando…
Demonstration of a Common DPhe(7) to DNal(2′)(7) Peptide Ligand Antagonist Switch for Melanocortin-3 and Melanocortin-4 Receptors Identifies the Systematic Mischaracterization of the Pharmacological Properties of Melanocortin Peptides
[Image: see text] Melanocortin peptides containing a 3-(2-naphthyl)-d-alanine residue in position 7 (DNal(2′)(7)), reported as melanocortin-3 receptor (MC3R) subtype-specific agonists in two separate publications, were found to lack significant MC3R agonist activity. The cell lines used at the Unive...
Autores principales: | Gimenez, Luis E., Noblin, Terry A., Williams, Savannah Y., Mullick Bagchi, Satarupa, Ji, Ren-Lei, Tao, Ya-Xiong, Jeppesen, Claus B., Conde-Frieboes, Kilian W., Sawyer, Tomi K., Grieco, Paolo, Cone, Roger D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059122/ https://www.ncbi.nlm.nih.gov/pubmed/35404053 http://dx.doi.org/10.1021/acs.jmedchem.1c01295 |
Ejemplares similares
-
Melanocortins, Melanocortin Receptors and Multiple Sclerosis
por: Lisak, Robert P., et al.
Publicado: (2017) -
When Macrocyclic
Peptides Meet the Crystal Structure
of a Melanocortin Receptor
por: Grieco, Paolo
Publicado: (2021) -
Melanocortin Peptide Therapy for the Treatment of Arthritic Pathologies
por: Getting, S. J., et al.
Publicado: (2009) -
Melanocortin Peptides: Potential Targets in Systemic Lupus Erythematosus
por: Loram, Lisa Carole, et al.
Publicado: (2014) -
Melanocortin Regulation of Inflammation
por: Wang, Wei, et al.
Publicado: (2019)